NEW Dividiend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

ALGN | NASDAQ

$177.50 $0.00 | 0.00%

Next Earnings: Jul 22, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
52-Week Range: $122.00 - $208.31

10 Year ALGN Performance Metrics:

Total Return (with DRIP): 109.8% (7.69% CAGR)
Total Return (no DRIP): 109.8% (7.69% CAGR)
Share Price: 109.8% (7.69% CAGR)
ALGN Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks.

[lev_ptables no_sale]

ALGN Earnings, Revenue, Cash & Debt, Shares Outstaning:

ALGN - Revenue
7-Day FREE Trial Get Full Access Now!
ALGN Revenue CAGR:1Y: 6.21%2Y: 2.12%5Y: 3.06%10Y: 15.86%
ALGN - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
ALGN EPS CAGR:1Y: 23.62%2Y: 6.28%5Y: -8.96%10Y: 12.12%
ALGN - Net Income
7-Day FREE Trial Get Full Access Now!
ALGN Net Income CAGR:1Y: 20.96%2Y: 3.62%5Y: -10.86%10Y: 10.77%
ALGN - EBITDA
7-Day FREE Trial Get Full Access Now!
ALGN EBITDA CAGR:1Y: 17.78%2Y: 4.79%5Y: -1.84%10Y: 13.46%
ALGN - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
ALGN Free Cash Flow CAGR:1Y: 339.10%2Y: 149.65%5Y: -8.13%10Y: 27.65%
ALGN - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
ALGN Free Cash Flow / Share CAGR:1Y: 352.24%2Y: 156.12%5Y: -6.26%10Y: 29.07%
ALGN - Operating Income
7-Day FREE Trial Get Full Access Now!
ALGN Operating Income CAGR:1Y: 31.71%2Y: 5.84%5Y: -5.19%10Y: 12.47%
ALGN - Gross Profit
7-Day FREE Trial Get Full Access Now!
ALGN Gross Profit CAGR:1Y: 8.30%2Y: 2.34%5Y: 1.70%10Y: 15.09%
ALGN - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
ALGN Shares Outstanding CAGR:1Y: -2.72%2Y: -2.49%5Y: -2.14%10Y: -1.26%
ALGN - Share Buybacks
7-Day FREE Trial Get Full Access Now!
ALGN Share Buybacks CAGR:1Y: -84.49%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ALGN - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
ALGN Stock-Based Comp CAGR:1Y: -9.05%2Y: 2.72%5Y: 8.48%10Y: 12.57%
ALGN - Expenses
7-Day FREE Trial Get Full Access Now!
ALGN Expenses CAGR:1Y: 21.73%2Y: 81.27%5Y: -6.65%10Y: 4.30%
ALGN - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
ALGN - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
ALGN - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
ALGN - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
ALGN - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
ALGN - Cash & Debt
7-Day FREE Trial Get Full Access Now!
ALGN - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
ALGN Revenue CAGR:1Y: 6.21%2Y: 2.12%5Y: 3.06%10Y: 15.86%
ALGN - Revenue by Region
7-Day FREE Trial Get Full Access Now!
ALGN Revenue CAGR:1Y: 6.21%2Y: 2.12%5Y: 3.06%10Y: 15.86%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ALGN - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ALGN Actual Revenue CAGR:1Y: 6.21%2Y: 2.12%5Y: 3.06%10Y: 15.86%
ALGN - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ALGN Actual EPS CAGR:1Y: 23.62%2Y: 6.28%5Y: -8.96%10Y: 12.12%
ALGN - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ALGN Actual Net Income CAGR:1Y: 20.96%2Y: 3.62%5Y: -10.86%10Y: 10.77%
ALGN - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
ALGN Actual EBITDA CAGR:1Y: 17.78%2Y: 4.79%5Y: -1.84%10Y: 13.46%

Ratios, Profit Margins & Return on Capital:

ALGN - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
ALGN Net Profit Margin CAGR:1Y: 13.87%2Y: 1.46%5Y: -13.50%10Y: -4.39%
ALGN - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
ALGN Gross Profit Margin CAGR:1Y: 1.97%2Y: 0.22%5Y: -1.32%10Y: -0.66%
ALGN - Price to Earnings
7-Day FREE Trial Get Full Access Now!
ALGN - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
ALGN - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
ALGN - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for ALGN

Based on past 10-year performance, here are ALGN growth metrics:

Share price CAGR of +7.93%
Dividend CAGR of +0%

Using ALGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ALGN (DRIP)ALGN - No DRIP
Current Price$177.50$177.50
Start Shares56.3456.34
Start Value$10,000$10,000
  
After 10 years:
Final Share Count56.3456.34
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$380.88$177.50
Total Dividends$0$0
Final Value$21,458$10,000

Estimated Future Value + Dividends - ALGN

NOTE: Above numbers are our estimate based on ALGN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

[lev_ptables no_sale]

Company Info

Align Technology, Inc. (ALGN) had its IPO on 2001-01-30, and is trader on NASDAQ stock exchange.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

ALGN website: https://www.aligntech.com


Get Full Access to All Reports with DRIPCalc PRO

[lev_ptables no_sale]